Yuan Yuan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Chemotherapy Induced

Patient Reported

Top Venues

Therapeutic advances in medical oncology

Cancer gene therapy

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Weili Xiong, Ting Xu, Xiao Liu, Lili Zhang, Yuan Yuan
Efficacy and safety of nanoparticle albumin-bound paclitaxel in taxane-pretreated metastatic breast cancer patients. Cancer (2024)
Weili Xiong, Ting Xu, Xiao Liu, Lili Zhang, Yuan Yuan
Efficacy and safety of nanoparticle albumin-bound paclitaxel in taxane-pretreated metastatic breast cancer patients. Cancer (2024)
Weili Xiong, Ting Xu, Xiao Liu, Lili Zhang, Yuan Yuan
Efficacy and safety of nanoparticle albumin-bound paclitaxel in taxane-pretreated metastatic breast cancer patients. Cancer 130 (S8) (2024)
Cong Wang, Chenguang Bai, Zhe Zhang, Hao Zhou, Huanyao Gao, Siwei Wang, Yuan Yuan
UGT1A7 altered HER2-positive breast cancer response to trastuzumab by affecting epithelial-to-mesenchymal transition: A potential biomarker to identify patients resistant to trastuzumab treatment. Cancer gene therapy (2024)
Weili Xiong, Ting Xu, Xiao Liu, Lili Zhang, Yuan Yuan
Efficacy and safety of nanoparticle albumin-bound paclitaxel in taxane-pretreated metastatic breast cancer patients. Cancer 130 (S8) (2024)
Yuan Yuan, Huanyao Gao, Yongxian Zhuang, Lixuan Wei, Jia Yu, Zhe Zhang, Lili Zhang, Liewei Wang
NDUFA4L2 promotes trastuzumab resistance in HER2-positive breast cancer. Therapeutic advances in medical oncology 13 (2021)
Jun Hua, Zhe Zhang, Lili Zhang, Yan Sun, Yuan Yuan
UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells. Cancer chemotherapy and pharmacology 88 (4) (2021)